Back to Search
Start Over
Reduced Walker 256 carcinosarcoma growth in vasopressin-deficient Brattleboro rats.
- Source :
-
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine [Tumour Biol] 2010 Dec; Vol. 31 (6), pp. 569-73. Date of Electronic Publication: 2010 Jun 18. - Publication Year :
- 2010
-
Abstract
- The growth pattern of carcinosarcoma Walker 256 was studied in rats with different levels of vasopressin in the blood. The Brattleboro rats are unable to synthesize vasopressin in a consequence of deletion in the coding gene. Hybrids from crossbreeding of the mutant Brattleboro and normal WAG rats inherit the one intact vasopressin gene and hold nearly normal hormone level. It was found that non-strain-specific carcinosarcoma Walker 256 intensively grows in WAG rats and their offsprings from crossbreeding with Brattleboro rats, and tumor development is equally terminated in them by death. Carcinosarcoma grows less intensely in Brattleboro rats; the tumor nodes increased only within the first 2 weeks, after which, the tumor began to decrease and eventually disappeared. Infusion of exogenous vasopressin to Brattleboro rats intensifies a tumor growth in the first 2 weeks after the inoculation of Walker 256 cells; however, it does not prevent a following regression and resorption of tumors.
- Subjects :
- Animals
Disease Models, Animal
Female
Male
Mammary Neoplasms, Experimental pathology
Neoplasm Transplantation
Rats
Rats, Brattleboro
Vasopressins blood
Vasopressins pharmacology
Carcinoma 256, Walker pathology
Cell Proliferation drug effects
Mammary Neoplasms, Animal pathology
Vasopressins deficiency
Subjects
Details
- Language :
- English
- ISSN :
- 1423-0380
- Volume :
- 31
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
- Publication Type :
- Academic Journal
- Accession number :
- 20559788
- Full Text :
- https://doi.org/10.1007/s13277-010-0070-4